Target intelligence / Profile preview

Dimethylsulfoniopropionate (DMSP)

Target
DMSP
Molecular classification
Small molecule, Organosulfur compound, Zwitterion, Osmolyte, Other
01

Overview

Dimethylsulfoniopropionate (DMSP) is a ubiquitous zwitterionic organosulfur metabolite primarily synthesized by marine phytoplankton, macroalgae, and some terrestrial plants [2, 4]. Within marine ecosystems, DMSP functions as a multi-purpose molecule, acting as a key osmolyte for salinity stress, a cryoprotectant in cold environments, and an antioxidant to combat reactive oxygen species [2, 7, 13]. It is a central figure in the global sulfur cycle because its microbial breakdown by DMSP lyases and demethylases yields dimethyl sulfide (DMS), a volatile gas that influences cloud formation and climate [5, 6, 8]. In recent years, DMSP has emerged as a promising bioactive compound in biomedical research, demonstrating potential neuroprotective, anti-aging, and anticancer effects [1, 3, 10]. It appears to exert these benefits by activating the SKN-1 (Nrf2-like) transcription factor, which enhances mitochondrial function, promotes autophagy, and strengthens cellular antioxidant defenses [1, 3]. Preclinical studies have shown that DMSP can protect neural cells from oxidative damage and even lead to the complete suppression of certain tumors in mouse models [3, 10].

Other names
3-DimethylsulfoniopropionateDimethyl-β-propiothetinDimethylpropiothetinS,S-Dimethyl-β-propiothetin3-(Dimethylsulfaniumyl)propanoate
02

Mechanism of action

As a bioactive small molecule, it activates the SKN-1/Nrf2 transcription factor pathway to enhance mitochondrial health and antioxidant response, promotes autophagy and mitophagy flux, and serves as a direct scavenger of reactive oxygen species.

03

Biological functions

OsmoregulationAntioxidant activityCryoprotectionMitochondrial function regulationAutophagy inductionSignal transductionOther
04

Disease associations

CancerNeurodegenerative diseaseAging-related declineOxidative stress-induced disordersOther
05

Safety considerations

Production of dimethyl sulfide (DMS) as a metabolic byproduct leads to strong, characteristic odorsLack of human clinical safety and efficacy dataHigh dosage requirements observed in preclinical therapeutic models
06

Biomarkers

Dimethyl sulfide (DMS) concentrationSKN-1/Nrf2 nuclear translocationMitochondrial membrane potentialAlpha-tubulin acetylation

Beyond the preview

Go deeper on Dimethylsulfoniopropionate (DMSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dimethylsulfoniopropionate (DMSP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call